The bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: a new therapeutic approach.
about
Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell NeoplasmsCurrent and emerging treatment options for hairy cell leukemiaTargeting neoplastic B cells and harnessing microenvironment: the "double face" of ibrutinib and idelalisibA Unique Hairy Cell Leukemia Variant.Novel therapeutic options for relapsed hairy cell leukemia.Targeting Bruton's tyrosine kinase with ibrutinib in B-cell malignancies.Pharmacodynamic considerations of small molecule targeted therapy for treating B-cell malignancies in the elderly.Targeting non-receptor tyrosine kinases using small molecule inhibitors: an overview of recent advances.Potential breakthroughs with investigational drugs for hairy cell leukemia.Ibrutinib-A double-edge sword in cancer and autoimmune disorders.Hairy cell leukemia: Past, present and future.Ibrutinib inhibits pre-BCR+ B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK.How I manage patients with hairy cell leukaemia.Time to Cure Hairy Cell Leukemia.Water Solubility Enhancement of Pyrazolo[3,4-d]pyrimidine Derivatives via Miniaturized Polymer-Drug Microarrays.Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
P2860
Q26795594-B767E9CE-78D2-4A91-B3A4-0C3EDBFF737DQ26796423-D4061C4D-4E3A-4BAA-855E-91DC97B93601Q27025812-E0B9B08A-90BD-4DB7-A431-C6F55127ED20Q37081892-4B83176F-8F31-4E89-9507-1E4096A72D5FQ38308974-3626F1CC-1B07-4E10-AD61-57027D79E197Q38351184-B19C347C-DE68-41A4-88A9-3FE5AD857D53Q38544216-81791F72-D0B6-4AB5-8B27-5702A92B72FAQ38554422-701E8757-07EC-4CE6-AF00-E653818E671EQ38578492-4B4743FE-B749-44BB-A561-2A04F297A7BAQ38585329-AE20B3E3-4E66-49FE-B283-0B9F7123970DQ38651453-D94E3CE7-B4EF-4EAA-8CEB-9AFA755697B8Q38723944-0B25BB2A-737F-4555-A523-F8C47D06C83AQ39113513-92287BFC-5AA7-48B1-9E68-443B4D13ACE5Q49742631-284B328B-7243-4B9B-A6EB-408DA1F772FDQ52655078-EE197F77-909A-4B1B-94EC-756DC3138863Q53381221-F8E2FC6F-91DF-4C6D-9FB5-4CD4D6344E6D
P2860
The bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: a new therapeutic approach.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The bruton tyrosine kinase inh ...... g: a new therapeutic approach.
@ast
The bruton tyrosine kinase inh ...... g: a new therapeutic approach.
@en
type
label
The bruton tyrosine kinase inh ...... g: a new therapeutic approach.
@ast
The bruton tyrosine kinase inh ...... g: a new therapeutic approach.
@en
prefLabel
The bruton tyrosine kinase inh ...... g: a new therapeutic approach.
@ast
The bruton tyrosine kinase inh ...... g: a new therapeutic approach.
@en
P2093
P2860
P356
P1476
The bruton tyrosine kinase inh ...... g: a new therapeutic approach.
@en
P2093
Evgeny Arons
Jan A Burger
Mariela Sivina
Robert J Kreitman
P2860
P304
P356
10.1111/BJH.12867
P407
P577
2014-04-02T00:00:00Z